samedan logo
 
 
 
spacer
home > ebr > autumn 2001 > distribution of temperature-sensitive products - when time is more than just money
PUBLICATIONS
European Biopharmaceutical Review

Distribution of Temperature-Sensitive Products - When Time is More than Just Money

Pharmaceutical Exports

The latest figures available from the Association of the British Pharmaceutical Industry put the value of UK pharmaceutical exports at 5.5 billion, making it one of the country's biggest international trade success stories and putting pharmaceutical exports at the heart of the knowledge-based economy. Furthermore, five of the world's top 20 medicines were developed in British laboratories.Nevertheless, whilst the worldwide health care market continues to soar, established pharmaceutical manufacturers face challenges on all fronts. The past is no longer a guide for the future, and blockbuster products are increasingly more difficult and costly to find. So what are these fundamental changes that are currently reshaping the pharmaceutical industry? Change is never from one source but comes about when a variety of factors begin to emerge.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer

By Mario Johnson, Pharmaceutical Industry Manager for DHL International (UK) Ltd 
A Business Studies Graduate from the Buckinghamshire Management College, Mario Johnson is the Pharmaceutical Industry Manager for DHL International (UK) Ltd. Mario joined DHL in 1993 and went on to become a Business Development Manager, first for DHL North East Region, and then for the Central Logistics Department.
In his role as Pharmaceutical Industry Manager, Mario works alongside a team of key account managers and is responsible for developing and implementing state-of-the-art delivery solutions.

spacer
Mario Johnson
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Nemera launches UniSpray, its unidose system primarily for systemic-acting drug administration

Nemera has a proven track record in developing and manufacturing complex Ear Nose and Throat solutions. In line with clear growing market interest in unidose system coupled with promising advantages that nasal route could offer, Nemera is thrilled to extend its portfolio by launching its unidose system, UniSpray, for systemic-acting drug administration to face emergency and crisis.
More info >>

White Papers

Modifying MDI Canister Surfaces to Improve Drug Stability & Drug Delivery

Presspart Manufacturing Ltd

Hydrofluoroalkane (HFA)-based propellants are widely used in modern metered-dose inhalers (MDIs), due to their lack hazardous and environmentally-damaging effects. However, an HFA's active pharmaceutical ingredient can interact with the canister substrate, causing deposition of the drug to the canister walls, or interact with the solution, causing degradation and resulting in increased impurity levels. Over the past few years, a number of surface coatings have been developed that can be applied to MDI canisters and valve components, to protect the contents from deposition and degradation. More recently, plasma processes have been developed to modify and improve the surface energy performance of a MDI canister. This approach has a number of advantages to alternative coatings but requires careful optimisation to ensure the highest quality finish and MDI performance. Richard Turner, Business Development Director, Presspart Manufacturing Ltd, explains.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement